Facense Israeli Company

Facense is developing smartglasses with small sensors on the frames that are capable of continuously and unobtrusively measuring the wearer's vital signs and emotional responses. Facense's technology enables the detection and prediction of various medical conditions, including hypertension, stroke, congestive heart failure, asthma, chronic obstructive pulmonary disease, and migraines, as well as early detection of COVID-19 symptomatic behavior.